Literature DB >> 21533512

Establishment and characterization of a new human gallbladder carcinoma cell line (OCUG-1) producing TA-4.

N Yamada1, Y Chung, H Ohtani, T Ikeda, N Onoda, T Sawada, Y Nishiguchi, T Hasuma, M Sowa.   

Abstract

A new human cell line (OCUG-1) was established from peritoneal effusion of a patient with malignant gallbladder carcinoma. OCUG-1 cells proliferated mainly in clusters of cells partially floating in a monolayered sheet. The population doubling time is 47.1 h. DNA analysis showed that OCUG-1 cells were aneuploid and had two G(0)/G(1) peaks. The number of chromosomes was distributed in a broad range from 52 to 139. Subcutaneous injections of the cells induced tumor formation in all nude mice. The reconstituted tumors were poorly differentiated adenocarcinoma. High levels of SLX, CA19-9, SPan-1 and TA-4 were found in the serum of the original patient, but OCUG-1 cells produced only TA-4. We speculate that OCUG-1 may be a transitional form from adenocarcinoma to squamous cell carcinoma. Since OCUG-1 produces a high level of TA-4, it will be useful for the study of the biological nature of this carcinoma and the relationship between the expression of TA-4 and squamatization.

Entities:  

Year:  1997        PMID: 21533512     DOI: 10.3892/ijo.10.6.1251

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Interleukin-8 produced from cancer-associated fibroblasts suppresses proliferation of the OCUCh-LM1 cancer cell line.

Authors:  Ryota Tanaka; Kenjiro Kimura; Shimpei Eguchi; Go Ohira; Shogo Tanaka; Ryosuke Amano; Hiroaki Tanaka; Masakazu Yashiro; Masaichi Ohira; Shoji Kubo
Journal:  BMC Cancer       Date:  2022-07-08       Impact factor: 4.638

2.  MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.

Authors:  Florian Posch; Felix Prinz; Amar Balihodzic; Christian Mayr; Tobias Kiesslich; Christiane Klec; Katharina Jonas; Dominik A Barth; Jakob M Riedl; Armin Gerger; Martin Pichler
Journal:  Cancers (Basel)       Date:  2021-08-08       Impact factor: 6.575

3.  Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer.

Authors:  Takashi Hirosawa; Masaharu Ishida; Kentaro Ishii; Keigo Kanehara; Katsuyoshi Kudo; Shinobu Ohnuma; Takashi Kamei; Fuyuhiko Motoi; Takeshi Naitoh; Florin M Selaru; Michiaki Unno
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

4.  Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets.

Authors:  David K Lau; Dmitri Mouradov; Wiphawan Wasenang; Ian Y Luk; Cameron M Scott; David S Williams; Yvonne H Yeung; Temduang Limpaiboon; George F Iatropoulos; Laura J Jenkins; Camilla M Reehorst; Fiona Chionh; Mehrdad Nikfarjam; Daniel Croagh; Amardeep S Dhillon; Andrew J Weickhardt; Toshihide Muramatsu; Yoshimasa Saito; Niall C Tebbutt; Oliver M Sieber; John M Mariadason
Journal:  iScience       Date:  2019-10-31

5.  CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.

Authors:  Yurie Yamamoto; Atsushi Sugimoto; Koji Maruo; Gen Tsujio; Tomohiro Sera; Shuhei Kushiyama; Sadaaki Nishimura; Kenji Kuroda; Shingo Togano; Shinpei Eguchi; Ryota Tanaka; Kenjiro Kimura; Ryosuke Amano; Masaichi Ohira; Masakazu Yashiro
Journal:  PLoS One       Date:  2022-04-04       Impact factor: 3.240

6.  Establishment and characterisation of six human biliary tract cancer cell lines.

Authors:  J-L Ku; K-A Yoon; I-J Kim; W-H Kim; J-Y Jang; K-S Suh; S-W Kim; Y-H Park; J-H Hwang; Y-B Yoon; J-G Park
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

7.  Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.

Authors:  Patricia García; Carolina Bizama; Lorena Rosa; Jaime A Espinoza; Helga Weber; Javier Cerda-Infante; Marianela Sánchez; Viviana P Montecinos; Justo Lorenzo-Bermejo; Felix Boekstegers; Marcela Dávila-López; Francisca Alfaro; Claudia Leiva-Acevedo; Zasha Parra; Diego Romero; Sumie Kato; Pamela Leal; Marcela Lagos; Juan Carlos Roa
Journal:  Biol Res       Date:  2020-04-15       Impact factor: 5.612

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.